These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

628 related items for PubMed ID: 12918061

  • 1. Vascular endothelial growth factor expression correlates with matrix metalloproteinases MT1-MMP, MMP-2 and MMP-9 in human glioblastomas.
    Munaut C, Noël A, Hougrand O, Foidart JM, Boniver J, Deprez M.
    Int J Cancer; 2003 Oct 10; 106(6):848-55. PubMed ID: 12918061
    [Abstract] [Full Text] [Related]

  • 2. Expression and activity of vascular endothelial growth factor and metalloproteinases in alveolar and embryonal rhabdomyosarcoma cell lines.
    Onisto M, Slongo ML, Gregnanin L, Gastaldi T, Carli M, Rosolen A.
    Int J Oncol; 2005 Sep 10; 27(3):791-8. PubMed ID: 16077930
    [Abstract] [Full Text] [Related]

  • 3. Expression of matrix metalloproteinases (MMP-2, MMP-9, MT1-MMP) and their inhibitors (TIMP-1, TIMP-2) in common epithelial tumors of the ovary.
    Sakata K, Shigemasa K, Nagai N, Ohama K.
    Int J Oncol; 2000 Oct 10; 17(4):673-81. PubMed ID: 10995877
    [Abstract] [Full Text] [Related]

  • 4. PAF-induced furin and MT1-MMP expression is independent of MMP-2 activation in corneal myofibroblasts.
    Ottino P, He J, Axelrad TW, Bazan HE.
    Invest Ophthalmol Vis Sci; 2005 Feb 10; 46(2):487-96. PubMed ID: 15671273
    [Abstract] [Full Text] [Related]

  • 5. Expression and localization of matrix metalloproteinases (MT1-MMP, MMP-2) and tissue inhibitor of metalloproteinase-2 (TIMP-2) during synepitheliochorial placentation of goats (Capra hircus).
    Uekita T, Yamanouchi K, Sato H, Tojo H, Seiki M, Tachi C.
    Placenta; 2004 Nov 10; 25(10):810-9. PubMed ID: 15451196
    [Abstract] [Full Text] [Related]

  • 6. Expression and activation of matrix metalloproteinase-2 (MMP-2) and its co-localization with membrane-type 1 matrix metalloproteinase (MT1-MMP) correlate with melanoma progression.
    Hofmann UB, Westphal JR, Zendman AJ, Becker JC, Ruiter DJ, van Muijen GN.
    J Pathol; 2000 Jul 10; 191(3):245-56. PubMed ID: 10878545
    [Abstract] [Full Text] [Related]

  • 7. Expression and tissue localization of membrane-type 1, 2, and 3 matrix metalloproteinases in human astrocytic tumors.
    Nakada M, Nakamura H, Ikeda E, Fujimoto N, Yamashita J, Sato H, Seiki M, Okada Y.
    Am J Pathol; 1999 Feb 10; 154(2):417-28. PubMed ID: 10027400
    [Abstract] [Full Text] [Related]

  • 8. Roles of membrane type 1 matrix metalloproteinase and tissue inhibitor of metalloproteinases 2 in invasion and dissemination of human malignant glioma.
    Nakada M, Kita D, Futami K, Yamashita J, Fujimoto N, Sato H, Okada Y.
    J Neurosurg; 2001 Mar 10; 94(3):464-73. PubMed ID: 11235952
    [Abstract] [Full Text] [Related]

  • 9. Hypoxia induces the expression of membrane-type 1 matrix metalloproteinase in retinal glial cells.
    Noda K, Ishida S, Shinoda H, Koto T, Aoki T, Tsubota K, Oguchi Y, Okada Y, Ikeda E.
    Invest Ophthalmol Vis Sci; 2005 Oct 10; 46(10):3817-24. PubMed ID: 16186369
    [Abstract] [Full Text] [Related]

  • 10. mRNA levels of membrane-type 1 matrix metalloproteinase (MT1-MMP), MMP-2, and MMP-9 and of their inhibitors TIMP-2 and TIMP-3 in normal thyrocytes and thyroid carcinoma cell lines.
    Hofmann A, Laue S, Rost AK, Scherbaum WA, Aust G.
    Thyroid; 1998 Mar 10; 8(3):203-14. PubMed ID: 9545106
    [Abstract] [Full Text] [Related]

  • 11. Matrix metalloproteinases in human gliomas: activation of matrix metalloproteinase-2 (MMP-2) may be correlated with membrane-type-1 matrix metalloproteinase (MT1-MMP) expression.
    Hur JH, Park MJ, Park IC, Yi DH, Rhee CH, Hong SI, Lee SH.
    J Korean Med Sci; 2000 Jun 10; 15(3):309-14. PubMed ID: 10895974
    [Abstract] [Full Text] [Related]

  • 12. Visfatin induces human endothelial VEGF and MMP-2/9 production via MAPK and PI3K/Akt signalling pathways: novel insights into visfatin-induced angiogenesis.
    Adya R, Tan BK, Punn A, Chen J, Randeva HS.
    Cardiovasc Res; 2008 May 01; 78(2):356-65. PubMed ID: 18093986
    [Abstract] [Full Text] [Related]

  • 13. Hypoxia activates matrix metalloproteinase expression and the VEGF system in monkey choroid-retinal endothelial cells: Involvement of cytosolic phospholipase A2 activity.
    Ottino P, Finley J, Rojo E, Ottlecz A, Lambrou GN, Bazan HE, Bazan NG.
    Mol Vis; 2004 May 17; 10():341-50. PubMed ID: 15162095
    [Abstract] [Full Text] [Related]

  • 14. Expression of matrix metalloproteinases, tissue inhibitors of metalloproteinases and vascular endothelial growth factor in canine mast cell tumours.
    Giantin M, Aresu L, Benali S, Aricò A, Morello EM, Martano M, Vascellari M, Castagnaro M, Lopparelli RM, Zancanella V, Granato A, Mutinelli F, Dacasto M.
    J Comp Pathol; 2012 Nov 17; 147(4):419-29. PubMed ID: 22520817
    [Abstract] [Full Text] [Related]

  • 15. Expression of matrix metalloproteinases and their tissue inhibitors in human brain tumors.
    Lampert K, Machein U, Machein MR, Conca W, Peter HH, Volk B.
    Am J Pathol; 1998 Aug 17; 153(2):429-37. PubMed ID: 9708803
    [Abstract] [Full Text] [Related]

  • 16. Production and activation of matrix metalloproteinase-2 in proliferative diabetic retinopathy.
    Noda K, Ishida S, Inoue M, Obata K, Oguchi Y, Okada Y, Ikeda E.
    Invest Ophthalmol Vis Sci; 2003 May 17; 44(5):2163-70. PubMed ID: 12714657
    [Abstract] [Full Text] [Related]

  • 17. Expression of MMP-2 and MMP-9, their inhibitors, and the activator MT1-MMP in primary breast carcinomas.
    Jones JL, Glynn P, Walker RA.
    J Pathol; 1999 Oct 17; 189(2):161-8. PubMed ID: 10547569
    [Abstract] [Full Text] [Related]

  • 18. Matrix metalloproteinase expression and function during fin regeneration in zebrafish: analysis of MT1-MMP, MMP2 and TIMP2.
    Bai S, Thummel R, Godwin AR, Nagase H, Itoh Y, Li L, Evans R, McDermott J, Seiki M, Sarras MP.
    Matrix Biol; 2005 Jun 17; 24(4):247-60. PubMed ID: 15935631
    [Abstract] [Full Text] [Related]

  • 19. Differential transcriptional activation of matrix metalloproteinase-2 and membrane type-1 matrix metalloproteinase by experimental deep venous thrombosis and thrombin.
    Dahi S, Lee JG, Lovett DH, Sarkar R.
    J Vasc Surg; 2005 Sep 17; 42(3):539-45. PubMed ID: 16171603
    [Abstract] [Full Text] [Related]

  • 20. Expression of integrin alpha(v)beta(3) correlates with activation of membrane-type matrix metalloproteinase-1 (MT1-MMP) and matrix metalloproteinase-2 (MMP-2) in human melanoma cells in vitro and in vivo.
    Hofmann UB, Westphal JR, Van Kraats AA, Ruiter DJ, Van Muijen GN.
    Int J Cancer; 2000 Jul 01; 87(1):12-9. PubMed ID: 10861447
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 32.